WEI-LUN Huang

Mr. WEI-LUN Huang


Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2011 in Journal of Clinical Microbiology
Verified
Journal Article
Open access
PDF file
WHWEI-LUN Huang
WEI-LUN Huang
TCTing-Lin Chi
Ting-Lin Chi
MWMei-Hua Wu
Mei-Hua Wu
RJRuwen Jou
Ruwen Jou
The GenoType MTBDRsltest and DNA sequencing were used to rapidly detect second-line drug- and ethambutol (EMB)-resistantMycobacterium tuberculosis. The ability of these two assays to detect the presence of mutations associated with resistance to fluoroquinolones (FLQ), aminoglycosides/cyclic peptide (AG/CP), and EMB in thegyrA,rrs, andembBgenes (for the GenoType MTBDRsltest) andgyrA,gyrB,rrs,eis,embC,embA,embB, andembRgenes (for DNA sequencing) was compared to that of conventional agar proportion drug susceptibility testing (DST). We evaluated 234 multidrug-resistant (MDR)M. tuberculosisisolates. The two molecular methods had high levels of specificity (95.8 to 100%). The sensitivities for FLQ resistance detection for both methods were 85.1%. For AG (kanamycin [KM] and amikacin [AM]) and CP (capreomycin CAP]), the sensitivities of resistance detection using the GenoType MTBDRsltest were 43.2%, 84.2%, and 71.4%, respectively, while with the inclusion of an extra gene,eis, in sequencing, the sensitivity reached 70.3% for detection of KM resistance. The sensitivities of EMB resistance detection were 56.2% and 90.7% with the GenoType MTBDRsltest and sequencing, respectively. We found that the GenoType MTBDRsltest can rapidly detect resistance to FLQ, CAP, and AM. The accuracy of the GenoType MTBDRsltest for the detection of FLQ and AM resistance was comparable to that of conventional DST; however, the test was less accurate for the detection of KM and EMB resistance and demonstrated a poor predictive value for CAP resistance. We recommend including new alleles consisting of theeispromoter andembBgenes in molecular analysis. However, conventional DST is necessary to rule out false-negative results from molecular assays.

10 December 2021 in Pathogens
Verified
Journal Article
Open access
PDF file
WHWEI-LUN Huang
WEI-LUN Huang
WFWen-Bin Fann
Wen-Bin Fann
RSRong-Jun Shen
Rong-Jun Shen
YCYi Chu
Yi Chu
JYJyh-Yuan Yang
Jyh-Yuan Yang
An outbreak of a new type of coronavirus pneumonia (COVID-19) began in Wuhan, Hubei Province, China, at the end of 2019, and it later spread to other areas of China and around the world. Taiwan reported the first confirmed case from an individual who returned from Wuhan, China, in January 2020 for Chinese New Year. Monitoring microbes in environmental sewage is an important epidemiological indicator, especially for pathogens that can be shed in feces such as poliovirus. We have conducted additional SARS-CoV-2 sewage testing since January 2020 using a well-established poliovirus environmental sewage surveillance system in Taiwan. Wastewater samples were collected from 11 sewage treatment plants from different parts of Taiwan twice a month for laboratory testing. By the end of July 2021, 397 wastewater specimens had been tested, and two samples were positive for SARS-CoV-2. These two wastewater samples were collected in the northern region of Taiwan from Taipei (site A) and New Taipei City (site C) at the beginning of June 2021. This result is consistent with the significant increase in confirmed COVID-19 cases observed in the same period of time. As the pandemic ebbed after June, the wastewater samples in these areas also tested negative for SARS-CoV-2 in July 2021.

1 March 2020 in Journal of the Formosan Medical Association
Verified
Journal Article
Open access
WHWEI-LUN Huang
WEI-LUN Huang
YLYu-Hsin Liao
Yu-Hsin Liao
YLYu-Jie Lin
Yu-Jie Lin
SWSheng-Tang Wei
Sheng-Tang Wei
SHSheng-Mou Hou
Sheng-Mou Hou
JYJyh-Yuan Yang
Jyh-Yuan Yang
Continuous strengthening of the safety of blood products to reduce the risk of transfusion-transmitted HCV in recipients is an important issue of Taiwanese government concern. Since 2013, highly sensitivity serology and NAT assays were simultaneously used for blood donation screening to shorten the window period of HIV, HBV and HCV infections. 15 cases of suspected transfusion-transmitted HCV infection were analyzed in 2015-2018. No HCV nucleic acid was detected among a total 91 bags of donated blood. Eleven cases among the 15 suspected recipients were positive for HCV nucleic acid, and 9 recipients had genotype results. Of these 9 recipients, five for genotype 1b (5/9, 55.6%), three for genotype 2a (3/9, 33.3%) and one for genotype 2b (1/9, 11.1%). We will continuously monitor the blood safety of recipients. There have been no confirmed cases of acute hepatitis C (AHC) infection due to transfusions of HCV contaminated blood product in 2015-2018 in Taiwan. Copyright (C) 2019, Formosan Medical Association. Published by Elsevier Taiwan LLC.